From: Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study
Process | Scoring and percentages | Pfizer (N = 20) | AstraZeneca (N = 13) | P-value |
---|---|---|---|---|
Transportation | Score/5 | 5.0 | 5.0 | – |
Percentage | 100.0 | 100.0 | ||
Handling and storage | Score/10 | 9.0 ± 1.3 | 8.9 ± 0.9 | 0.848 |
Percentage | 90.0 ± 12.5 | 89.2 ± 8.6 | ||
Vaccine preparation | Score/7 | 6.3 ± 1.4 | 5.9 ± 1.0 | 0.478 |
Percentage | 89.3 ± 20.1 | 84.6 ± 14.8 | ||
Pfizer preparation | Score/11 | 9.7 ± 1.8 | – | – |
Percentage | 87.7 ± 16.5 | – | ||
AstraZeneca preparation | Score/5 | – | 4.7 ± 0.5 | – |
Percentage | – | 93.8 ± 9.6 | ||
Pre-vaccination | Score/5 | 4.5 ± 0.9 | 3.9 ± 1.4 | 0.213 |
Percentage | 89.0 ± 18.9 | 78.5 ± 28.8 | ||
Administration | Score/8 | 7.9 ± 0.3 | 8.0 | 0.253 |
Percentage | 98.8 ± 3.8 | 100.0 | ||
Post-vaccination | Score/4 | 3.3 ± 0.7 | 3.2 ± 0.8 | 0.803 |
Percentage | 82.5 ± 18.3 | 80.8 ± 20.8 | ||
Total score** | Score/39 | 35.9 ± 2.5 | 35.0 ± 2.3 | 0.305 |
Percentage | 92.0 ± 6.4 | 89.7 ± 5.9 |